Glucose-Insulin-Potassium and Tri-Iodothyronine Individually Improve Hemodynamic Performance and Are Associated With Reduced Troponin I Release After On-Pump Coronary Artery Bypass Grafting | Zendy

Aaron Ranasinghe | Zendy; David Quinn | Zendy; Duilio Pagano | Zendy; Nicola C. Edwards | Zendy; Muzzafar Faroqui | Zendy; Timothy R. Graham | Zendy; Bruce Keogh | Zendy; Jorge Mascaro | Zendy; D. W. Riddington | Zendy; Stephen J. Rooney | Zendy; Jonathan N. Townend | Zendy; Ian C. Wilson | Zendy; Robert S. Bonser | Zendy

Open Access

Glucose-Insulin-Potassium and Tri-Iodothyronine Individually Improve Hemodynamic Performance and Are Associated With Reduced Troponin I Release After On-Pump Coronary Artery Bypass Grafting

Author(s) -

Aaron Ranasinghe,

David Quinn,

Duilio Pagano,

Nicola C. Edwards,

Muzzafar Faroqui,

Timothy R. Graham,

Bruce Keogh,

Jorge Mascaro,

D. W. Riddington,

Stephen J. Rooney,

Jonathan N. Townend,

Ian C. Wilson,

Robert S. Bonser

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.000786

Subject(s) - medicine , placebo , troponin i , hemodynamics , insulin , anesthesia , artery , cardiology , surgery , myocardial infarction , alternative medicine , pathology

Both glucose-insulin-potassium (GIK) and tri-iodothyronine (T3) may improve cardiovascular performance after coronary artery surgery (CABG) but their effects have not been directly compared and the effects of combined treatment are unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research